TAZLUM Trademark

Trademark Overview


On Monday, December 9, 2013, a trademark application was filed for TAZLUM with the United States Patent and Trademark Office. The USPTO has given the TAZLUM trademark a serial number of 86138173. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, July 31, 2017. This trademark is owned by Eli Lilly and Company. The TAZLUM trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of Alzheimer's, anxiety disorders, atherosclerosis, autoimmune diseases and disorders, blood disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cholesterol disorders, cystic fibrosis, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, gastrointestinal diseases and disorders, hormonal diseases and disorders, inflammation and inflammatory diseases and disorders, kidney diseases and disorders, liver diseases and disorders, metabolic diseases and disorders, migraines, muscle diseases and disorders, neurodegenerative diseases and disorders, neurological disorders, pain, pancreatic diseases and disorders, psychiatric disorders, sleep disorders, urological disorders; antidepressants; Diagnostic agents and substances for medical purposes; radiopharmaceutical diagnostic prepara...
tazlum

General Information


Serial Number86138173
Word MarkTAZLUM
Filing DateMonday, December 9, 2013
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, July 31, 2017
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 29, 2014

Trademark Statements


Goods and ServicesPharmaceutical preparations, namely, pharmaceutical preparations for the treatment of Alzheimer's, anxiety disorders, atherosclerosis, autoimmune diseases and disorders, blood disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cholesterol disorders, cystic fibrosis, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, gastrointestinal diseases and disorders, hormonal diseases and disorders, inflammation and inflammatory diseases and disorders, kidney diseases and disorders, liver diseases and disorders, metabolic diseases and disorders, migraines, muscle diseases and disorders, neurodegenerative diseases and disorders, neurological disorders, pain, pancreatic diseases and disorders, psychiatric disorders, sleep disorders, urological disorders; antidepressants; Diagnostic agents and substances for medical purposes; radiopharmaceutical diagnostic preparations for use in the diagnosis of neurodegenerative amyloid diseases

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, December 20, 2013
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameEli Lilly and Company
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressIndianapolis, IN 46285

Party NameEli Lilly and Company
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressIndianapolis, IN 46285

Trademark Events


Event DateEvent Description
Monday, July 31, 2017ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, July 31, 2017ABANDONMENT - NO USE STATEMENT FILED
Thursday, March 9, 2017ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, March 9, 2017TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, December 6, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, December 5, 2016EXTENSION 5 GRANTED
Tuesday, November 29, 2016EXTENSION 5 FILED
Tuesday, November 29, 2016TEAS EXTENSION RECEIVED
Thursday, March 31, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, March 30, 2016EXTENSION 4 GRANTED
Friday, March 25, 2016EXTENSION 4 FILED
Friday, March 25, 2016TEAS EXTENSION RECEIVED
Friday, October 2, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, October 1, 2015EXTENSION 3 GRANTED
Tuesday, September 29, 2015EXTENSION 3 FILED
Tuesday, September 29, 2015TEAS EXTENSION RECEIVED
Friday, May 29, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, May 28, 2015EXTENSION 2 GRANTED
Friday, May 15, 2015EXTENSION 2 FILED
Wednesday, May 27, 2015CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, May 15, 2015TEAS EXTENSION RECEIVED
Saturday, December 20, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, December 19, 2014EXTENSION 1 GRANTED
Friday, November 7, 2014EXTENSION 1 FILED
Wednesday, December 17, 2014CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, December 15, 2014CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, November 7, 2014TEAS EXTENSION RECEIVED
Tuesday, June 24, 2014NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 29, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 29, 2014PUBLISHED FOR OPPOSITION
Wednesday, April 9, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, March 19, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 19, 2014ASSIGNED TO EXAMINER
Friday, December 20, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, December 12, 2013NEW APPLICATION ENTERED IN TRAM